If you ask me - [opinion first person]

Other than inkjet printing, there have been few commercial successes from microfluidics technology. New companies entering the lab-on-chip (LOC) or point-of-care diagnostics (POC-Dx) space must have patent coverage in place for the core microfluidics technology, for which licensing is rarely seen as a viable strategy.